Почетна › Кронова болест › Охајо
Kliničke studije za Кронова болест u državi Охајо
28 studija za Кронова болест traži učesnike na lokacijama u državi Охајо.
Gradovi u državi Охајо
Zvanični tekst studije (na engleskom)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03816345A Study of SL-325 in Crohn's Disease Patients
- Clinical Trial Site, Cincinnati
- Clinical Trial Site, Columbus
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 12. 11. 2026. · NCT07753850A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Great Lakes Gastroenterology Research, LLC ( Site 5016), Mentor
Тражи се учесникФаза 3
Узраст од 16 до 80 · Оба пола · Ажурирано 10. 11. 2026. · NCT06430801Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Gastro Intestinal Research Institute of Northern Ohio, LLC, Westlake
Тражи се учесникФаза 3
Узраст од 18 до 70 · Оба пола · Ажурирано 4. 11. 2026. · NCT06937099A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Great Lakes Gastroenterology Research, LLC, Mentor
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07577843A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Cincinnati Children's Hospital Medical Center, Cincinnati
Тражи се учесникФаза 3
Узраст 3 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06663332A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- The Children's Medical Center of Dayton, Dayton
Тражи се учесникФаза 3
Узраст од 2 до 17 · Оба пола · Ажурирано 3. 11. 2026. · NCT05923073A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Great Lakes Gastroenterology Research, LLC, Mentor
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07499232A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- Great Lakes Gastroenterology Research, LLC, Mentor
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 2. 11. 2026. · NCT06233461A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastro Health Research - Cincinnati, Cincinnati
- DSI Research Northridge LLC, Dayton
- Gastro Health Research - Liberty Township, Liberty Township
- и још 3
Тражи се учесникФаза 4
Узраст од 18 до 80 · Оба пола · Ажурирано 28. 10. 2026. · NCT06581328Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Dayton Gastroenterology - Beavercreek /ID# 284065, Beavercreek
- Gastro Intestinal Research Institute of Northern Ohio /ID# 283860, Westlake
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 10. 2026. · NCT07697456A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Ohio Gastroenterology Group Inc.-Site Number: 8400006, Columbus
- Medical Associates Research Group-Site Number: 8400063, Columbus
- OSU Wexner Medical Center-Site Number: 8400077, Columbus
- и још 1
Тражи се учесникФаза 3
Узраст од 16 до 80 · Оба пола · Ажурирано 21. 10. 2026. · NCT07184944An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Gastroenterology & Hepatology Specialists, Inc.-Site nUmber: 8400139, Canton
- University Hospitals Cleveland Medical Center-Site Number: 8400073, Cleveland
- Ohio Gastroenterology Group Inc.-8400006, Columbus
- и још 5
Тражи се учесникФаза 3
Узраст од 16 до 80 · Оба пола · Ажурирано 21. 10. 2026. · NCT07184931A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Cleveland Clinic - Cleveland /ID# 256453, Cleveland
Тражи се учесникФаза 3
Узраст од 2 до 17 · Оба пола · Ажурирано 20. 10. 2026. · NCT05995353A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- University Children's Clinic, Cleveland
- Cleveland Clinic, Cleveland
Тражи се учесникФаза 3
Узраст од 2 до 17 · Оба пола · Ажурирано 9. 10. 2026. · NCT06405087A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Childrens Medical Center, Dayton
Тражи се учесникФаза 3
Узраст од 2 до 17 · Оба пола · Ажурирано 7. 10. 2026. · NCT05509777Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- University of Cincinnati /ID# 265589, Cincinnati
- The Ohio State University /ID# 265577, Columbus
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 25. 9. 2026. · NCT06548542Non-nutritive Sweeteners in Inflammatory Bowel Disease
- UH Minoff Health Center, Chagrin Falls
- University Hospitals Cleveland Medical Center, Cleveland
- UH Westlake Health Center, Westlake
Тражи се учесникЗдраве особе су добродошле
Узраст од 18 до 70 · Оба пола · Ажурирано 25. 9. 2026. · NCT07769437Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD
- Cleveland Clinic, Cleveland
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 27. 8. 2026. · NCT07680283Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- University of Cincinnati, Cincinnati
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 5. 8. 2026. · NCT07237516A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- University Hospitals Cleveland Medical Center - 11100 Euclid Ave, Cleveland
Тражи се учесникФаза 3
Узраст 2 и старији · Оба пола · Ажурирано 7. 5. 2026. · NCT05442567A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- University Hospitals Cleveland Medical Center, Cleveland
Тражи се учесникФаза 3
Узраст од 2 до 17 · Оба пола · Ажурирано 5. 5. 2026. · NCT04779320Precise Infliximab Exposure and Pharmacodynamic Control
- Cincinnati Children's Hospital, Cincinnati
- Cleveland Clinic Children's Hospital, Cleveland
- Nationwide Children's Hospital, Columbus
Тражи се учесникФаза 2/3
Узраст од 6 до 22 · Оба пола · Ажурирано 5. 5. 2026. · NCT05660746Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- OSU Inflammatory Bowel Disease Center, Hilliard
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 4. 2026. · NCT06456593A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Cincinnati
- Mirador Therapeutics Selected Site, Liberty Township
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 12. 3. 2026. · NCT07113522Treatment of Moderate to Severe Refractory Crohn's Disease
- Cleveland Clinic, Cleveland
Тражи се учесникФаза 1/2
Узраст од 18 до 65 · Оба пола · Ажурирано 10. 12. 2025. · NCT06721962Evaluation of the SMART IBD App in Pediatric IBD
- Cincinnati Children's Hospital Medical Center, Cincinnati
Тражи се учесник
Узраст од 13 до 17 · Оба пола · Ажурирано 21. 11. 2025. · NCT07195123Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy
- Cleveland Clinic Foundation, Cleveland
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2025. · NCT06670638Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.